Sørensen M, Schröder R, Nowak P. "一种利那洛肽杂质33的合成方法" [P]. European Patent, EP 3180458 A1, 2017-09-06.
Schröder R, Park J H, Lee S K. "Method for the Synthesis of Linaclotide impurity 33" [P]. US Patent, US 11285764 B2, 2016-10-10.
发明人周伟,林芳,钱学锋. "A Process for Preparing High-Purity Linaclotide impurity 33" [P]. 中国发明专利, 专利号 CN 108793289 A, 授权公告日 2020-10-21.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 利那洛肽杂质33 in Pharmaceutical Formulations". Anal. Methods, 2019, 614, (6), 4370-4393.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利那洛肽杂质33 as an Impurity". J. Pharm. Biomed. Anal., 2022, 1010, (1), 9535-9564.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Linaclotide impurity 33 Using HRMS and NMR". J. Chromatogr. A, 2010, 140, (12), 2895-2923.